
{
    "credit": [
        {
            "email": "ochsm@tcnj.edu",
            "name": "Michael F. Ochs",
            "typeEntity": "Person",
            "typeRoles": [
                "Primary contact"
            ]
        }
    ],
    "documentation": [
        {
            "url": "http://bioconductor.org/packages/release/bioc/html/OGSA.html"
        }
    ],
    "download": [
        {
            "type": "Source code",
            "url": "http://bioconductor/packages/release/bioc/src/contrib/OGSA_1.4.0.tar.gz"
        }
    ],
    "function": [
        {
            "operation": [
                {
                    "term": "Pathway or network analysis",
                    "uri": "http://edamontology.org/operation_2497"
                }
            ]
        }
    ],
    "labels": {
        "collectionID": [
            "BioConductor"
        ],
        "language": [
            "R"
        ],
        "license": "GPL-2.0",
        "operatingSystem": [
            "Linux",
            "Windows",
            "Mac"
        ],
        "toolType": [
            "Command-line tool",
            "Library"
        ],
        "topic": [
            {
                "term": "Molecular interactions, pathways and networks",
                "uri": "http://edamontology.org/topic_0602"
            },
            {
                "term": "Gene regulation",
                "uri": "http://edamontology.org/topic_0204"
            },
            {
                "term": "Oncology",
                "uri": "http://edamontology.org/topic_2640"
            }
        ]
    },
    "publication": [
        {
            "abstract": "Pathway deregulation has been identified as a key driver of carcinogenesis, with proteins in signaling pathways serving as primary targets for drug development. Deregulation can be driven by a number of molecular events, including gene mutation, epigenetic changes in gene promoters, overexpression, and gene amplifications or deletions. We demonstrate a novel approach that identifies pathways of interest by integrating outlier analysis within and across molecular data types with gene set analysis. We use the results to seed the top-scoring pair algorithm to identify robust biomarkers associated with pathway deregulation. We demonstrate this methodology on pediatric acute myeloid leukemia (AML) data. We develop a biomarker in primary AML tumors, demonstrate robustness with an independent primary tumor data set, and show that the identified biomarkers also function well in relapsed pediatric AML tumors. Â© 2004-2012 IEEE.",
            "authors": [
                "Ochs M.F.",
                "Farrar J.E.",
                "Considine M.",
                "Wei Y.",
                "Meshinchi S.",
                "Arceci R.J."
            ],
            "cit_count": 5,
            "doi": "10.1109/TCBB.2013.153",
            "journal": "IEEE/ACM Transactions on Computational Biology and Bioinformatics",
            "title": "Outlier analysis and top scoring pairfor integrated data analysisand biomarker discovery",
            "type": "Other",
            "year": "2014-01-01"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:ogsa",
        "biotoolsID": "ogsa",
        "description": "Provides a global estimate of pathway deregulation in cancer subtypes by integrating the estimates of significance for individual pathway members that have been identified by outlier analysis.",
        "homepage": "http://bioconductor.org/packages/release/bioc/html/OGSA.html",
        "name": "OGSA",
        "version": [
            "1.4.0"
        ]
    }
}